Adalimumab concentration-based tapering strategy: as good as the recommended dosage
Ann Rheum Dis
.
2018 Apr;77(4):473-475.
doi: 10.1136/annrheumdis-2017-212376.
Epub 2018 Jan 6.
Authors
Denis Mulleman
1
,
Alejandro Balsa
2
Affiliations
1
Department of Rheumatology, Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France.
2
Department of Rheumatology, Health Research Institute (IdiPAZ), Hospital Universitario La Paz, Madrid, Spain.
PMID:
29306871
PMCID:
PMC5890625
DOI:
10.1136/annrheumdis-2017-212376
No abstract available
Keywords:
anti-TNF; rheumatoid arthritis; treatment.
Publication types
Editorial
Comment
MeSH terms
Adalimumab
Antirheumatic Agents*
Arthritis, Rheumatoid*
Humans
Substances
Antirheumatic Agents
Adalimumab